Current Affairs
Select Date

Sun Pharma ICGEB Deal to Develop India's first Dengue Vaccine

India’s largest pharmaceutical company Sun Pharma has signed deal with International Centre for Genetic Engineering and Biotechnology (ICGEB) for clinical development Cissampelos pariera (Cipa).
•    It is India’s first vaccine (drug) for the treatment of dengue. 
•    The partnership between Sun Pharma and ICGEB aims to develop` safe, effective and affordable botanical drug Cipa. 
•    Under the deal, Sun Pharma will get access to all the intellectual properties (IP) rights of the drug across 17 countries. 
•    ICGEB will establish assay systems for the development of Cipa for the treatment of dengue infection. 
•    India is dengue-endemic resource-poor country representing 50% of the global population estimated to be at risk of dengue virus. 
•    This will be for the first time a vaccine developed entirely in India for a vector-borne disease that has been advanced for clinical development in the country. 


All Rights Reserved Top Rankers